CLabenz (@c_labenz) profile picture

CLabenz

@c_labenz
Joined January 2022
  • Tweets118
  • Following171
  • Followers149
5Media
Photo by CLabenz (@c_labenz)Photo by CLabenz (@c_labenz)Photo by CLabenz (@c_labenz)Photo by CLabenz (@c_labenz)Photo by CLabenz (@c_labenz)
We are pleased to announce that registration for ISHEN2025 is now open! ishen.org/ishen-2025/registr… We are accepting late breaking abstracts ishen.org/ishen-2025/abstrac… NOTE: There is very limited space. Registration will be open until full capacity 👉 Register today!
Image from International Society for Hepatic Encephalopathy (@ISHENliver)
8
2
8
2,467
🚨 #GIHepFellowshipBootcamp is heating up with these 🔥 📑s on #HepaticEncephalopathy 🧠 ⭐️ Testing for CHE‼️ ⭐️ Risk factors for OHE‼️ ⭐️ Preventing OHE‼️ ⭐️ ⭐️ Treating HE ‼️ 💊 💩 journals.lww.com/hepcomm/ful… journals.lww.com/hepcomm/ful…
Image from Hepatology Communications (@HepCommJournal)
Image from Hepatology Communications (@HepCommJournal)
20
37
4,942
📄 Full paper: journal-of-hepatology.eu/act… 📚 Related paper challenging the 24h albumin new rule: pubmed.ncbi.nlm.nih.gov/4025… #EASL2025
7
15
885
💉 Albumin duration & AKI response in cirrhosis Eva M. Schleicher (Mainz) – #EASL2025 🕒 24h albumin new rule questioned 🏆 EASL AKI response definition wins 📈 20% of 24h NR improved at 48h ⚖️ Early vs late responders: Same mortality 🚨 Cr ↑ >16% @24h → terlipressin! 👇
Image from The Baveno Cooperation: an EASL Consortium (@BavenoCoop)
Image from The Baveno Cooperation: an EASL Consortium (@BavenoCoop)
Image from The Baveno Cooperation: an EASL Consortium (@BavenoCoop)
Image from The Baveno Cooperation: an EASL Consortium (@BavenoCoop)
1
57
1
160
14,561
Today’s #readoftheweek📚discusses QuickStroop, which is a rapid screening tool to identify patients at risk for PHES-MHE, especially in patients below 60 years of age. Read here this @JHEP_Reports article: jhep-reports.eu/article/S258… 🙏@c_labenz @SJGairing @kaps_leonard @EvSchleicher @Maria_M_Gabriel @HeinerWedemeyer @b_maasoumy et al. #LiverTwitter #LiverX
Image from EASLnews (@EASLnews)
9
9
1,318
❗QuickStroop for screening for minimal hepatic encephalopathy in patients with #cirrhosis 🔓#OpenAccess at 👉jhep-reports.eu/article/S258… #LiverTwitter
Image from JHEP Reports (@JHEP_Reports)
11
23
1,764
Non-Invasive CSPH Estimated Risk (NICER) model including @Echosens SSM by VCTE at 100Hz 👉Developed (2020-2022) & validated (2023) in contemporary pts. 👉Outperforms ANTICIPATE(-NASH): AUC consistently >0.9. 👉Well-calibrated. 👉Sets a new standard IMHO. #LiverTwitter 🔗👇
Image from Mattias Mandorfer (@MattiasMandorf1)
4
20
1
46
4,673
Thrilled to have this work out in @HEP_Journal ! Short version: The problem - it’s hard to diagnose minimal HE or predict future overt HE in clinic What we found - automated speech analysis can do both
Image from Patty Pringle Bloom, M.D. (@BloomPringle)
4
26
3
87
12,147
"No value of non-selective beta-blockers after TIPS-insertion" published 'open access' at bit.ly/3AF9rjs #livertwitter #TIPS
In this study comprising 305 patients with transjugular intrahepatic portosystemic shunt (TIPS)-insertion, treatment with non-selective beta-blockers (NSBB) after successful portal pressure reduction via TIPS was not associated with lowered risk for hepatic or cardiac decompensation and mortality. Similarly, no impact on systemic inflammation, as measured by WBC, CRP and systemic inflammatory markers (SIM), during follow-up was found.

ALT In this study comprising 305 patients with transjugular intrahepatic portosystemic shunt (TIPS)-insertion, treatment with non-selective beta-blockers (NSBB) after successful portal pressure reduction via TIPS was not associated with lowered risk for hepatic or cardiac decompensation and mortality. Similarly, no impact on systemic inflammation, as measured by WBC, CRP and systemic inflammatory markers (SIM), during follow-up was found.

1
19
1
41
5,206
WHAT'S AT STEAK IN NUTRITION FOR HEPATIC ENCEPHALOPATHY? No one had more fun than me and @c_labenz writing this editorial: journals.lww.com/ctg/pages/a… On @JasmohanBajaj trial of meat vs veg burgers and ammonia: journals.lww.com/ctg/fulltex…
Food for the Brain: Is Vegan/Vegetarian Diet the... : Clinical and Translational Gastroenterology

Food for the Brain: Is Vegan/Vegetarian Diet the... : Clinical and Translational Gastroenterology

High-protein diet is the cornerstone of supportive care for patients living with hepatic encephalopathy. Although any protein source is better than...

journals.lww.com
8
17
4
73
14,937
Today @EASLnews, Martin Kabelitz presents his poster about the impact of #TIPS on frailty: 💪 Frailty has the potential to improve after TIPS insertion 🏋🏽 Especially patients with a high degree of frailty show improvement SAT-090 #EASL2024
Image from Maasoumy_liverlab (@Maasoumy_lab)
3
10
1,014
Replying to @mathiasjachs
@mathiasjachs & the Non-Invasive CSPH Estimated Risk (NICER) model based on a contemporary cohort integrating SSM-100Hz 👏 👉 Developed in SLD & 🦠 suppression/cure 👉 Improved discrimination & calibration. 👉 It's just the NICER model, I guess! 😜 Thanks @BavenoCoop!
Image from Mattias Mandorfer (@MattiasMandorf1)
1
7
23
869
Brilliant State of the Art talk by @dthabut on hepatic encephalopathy 🤩 Love that HE is getting this spotlight @EASLnews As the Professor stated: HE is the worst complication of cirrhosis We have a lot of work to do to improve this for our patients
Image from Patty Pringle Bloom, M.D. (@BloomPringle)
1
10
28
2,355
1+ 1 = 3 Lactulose + Rifaximin = Reduced episodes of hepatic encephalopathy journals.lww.com/hepcomm/ful… @HepCommJournal
Image from Elliot Tapper (@ebtapper)
4
79
5
292
32,398
There is no stepwise increase in the risk of encephalopathy with worsening psychometric scores in this international study journals.lww.com/hepcomm/ful… @HepCommJournal @SJGairing @BloomPringle @c_labenz
PHES scores have limited impact on the risk of... : Hepatology Communications

PHES scores have limited impact on the risk of... : Hepatology Communications

Background:Minimal hepatic encephalopathy, defined by the portosystemic hepatic encephalopathy score (PHES), is associated with a higher risk of...

journals.lww.com
1
12
24
4,978
🔑Are all proteins🟰 for ammoniagenesis? No! 🔑Can one meal change affect ⬇️#ammonia in #cirrhosis? Yes! ✅our #RCT where 1⃣ meal change from 🥩to 🌱/🌿-based was enough to⬇️#ammonia ! 🔑Impt because replacing full diets⛔️ 🔑metabolomic changes @ACG_CTG ⤵️ journals.lww.com/ctg/abstrac…
Image from Jasmohan Bajaj (@JasmohanBajaj)
Image from Jasmohan Bajaj (@JasmohanBajaj)
Image from Jasmohan Bajaj (@JasmohanBajaj)
Image from Jasmohan Bajaj (@JasmohanBajaj)
2
26
4
75
13,880
🟪NEW Article in press❕ Proton pump inhibitor use and risk of hepatic encephalopathy: a multicenter study 🔓#OpenAccess at 👉jhep-reports.eu/article/S258… #LiverTwitter #HepaticEncephalopathy
Image from JHEP Reports (@JHEP_Reports)
25
67
4,409
Are you busy with #hepatology clinical work? Check out the clinical care points in this short and concise review on the cerebral effects of #cirrhosis and #portalhypertension from a group of @ISHENliver members. Out now in Clinics in #LiverDisease. 👇 authors.elsevier.com/a/1i-BM…
Image from MetteMunkLauridsen (@MMLauridsen)
6
16
811
Is PPI use associated with HE? Our multicenter study says no 🚫 ✅1160 patients with PHES at baseline 🚫no association between PPI use and MHE or OHE development 🚫>70% without an indication for a PPI prescription❗️ 👉read the study here: jhep-reports.eu/article/S258…
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study

Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study

Data on the association between proton pump inhibitor (PPI) use and hepatic encephalopathy (HE) are conflicting, and data from multicentre studies are scarce. The aim of this study was to dissect the...

jhep-reports.eu
6
9
3
45
7,520
Grateful for an amazing team effort! @SJGairing @MontagneseSara @BloomPringle @MMLauridsen @jumarquardt @ISHENliver @JHEP_Reports
1
5
363
Load more